The non-small cell lung cancer cell line H3255 harbors amplified EGFR(L858R), but in the gefitinib-resistant derivative cell line H3255GR only a subset up alleles carry the additional T790M mutation that confers resistance to gefitinib but sensitizes to the allosteric inhibitor35. This evidence concerns the gene EGFR and non-small cell lung carcinoma.